These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 38668597

  • 1. The Complex Role of Botulinum Toxin in Enhancing Goal Achievement for Post-Stroke Patients.
    Săndulescu MI, Cinteză D, Poenaru D, Potcovaru CG, Păunescu H, Coman OA.
    Toxins (Basel); 2024 Mar 31; 16(4):. PubMed ID: 38668597
    [Abstract] [Full Text] [Related]

  • 2. [Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].
    Khat'kova SE, Baikova A, Maisonobe P, Khasanova DR.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021 Mar 31; 121(11):39-48. PubMed ID: 34932284
    [Abstract] [Full Text] [Related]

  • 3. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L, BoTULS investigators.
    Health Technol Assess; 2010 May 31; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [Abstract] [Full Text] [Related]

  • 4. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
    Marque P, Denis A, Gasq D, Chaleat-Valayer E, Yelnik A, Colin C, Botuloscope Group, Pérennou D.
    Ann Phys Rehabil Med; 2019 Jul 31; 62(4):207-213. PubMed ID: 31229700
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Frequency and characteristics of goal attainment following BoNT-A injection for management of spasticity.
    Mullins D, Winter A, Fini N, Dixon C, Aldous S, Palit M, Holland AE.
    Disabil Rehabil; 2016 Sep 31; 38(19):1927-33. PubMed ID: 26714558
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of botulinum toxin A for the treatment of hemiparesis in adults with chronic upper limb spasticity.
    Ghroubi S, Alila S, Elleuch W, Ayed HB, Mhiri C, Elleuch MH.
    Pan Afr Med J; 2020 Sep 31; 35():55. PubMed ID: 32523646
    [Abstract] [Full Text] [Related]

  • 8. [Treatment goals in patients with post-stroke upper limb spasticity following injection of botulinum toxin A : Results of the German-Austrian subgroup of the ULIS-II study].
    Fheodoroff K, Dressler D, Woldag H, Koßmehl P, Koch M, Maisonobe P, Reichel G.
    Nervenarzt; 2019 Apr 31; 90(4):361-370. PubMed ID: 30324541
    [Abstract] [Full Text] [Related]

  • 9. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R, Akturk S, Ersoy Y.
    Eur J Phys Rehabil Med; 2018 Oct 31; 54(5):738-744. PubMed ID: 29422486
    [Abstract] [Full Text] [Related]

  • 10. Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study.
    Turner-Stokes L, Jacinto J, Fheodoroff K, Brashear A, Maisonobe P, Lysandropoulos A, Ashford S, Upper Limb International Spasticity (ULIS-III) study group.
    J Rehabil Med; 2021 Feb 24; 53(2):jrm00157. PubMed ID: 33616192
    [Abstract] [Full Text] [Related]

  • 11. Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?
    Nott MT, Barden HL, Baguley IJ.
    J Rehabil Med; 2014 Oct 24; 46(9):864-8. PubMed ID: 25074437
    [Abstract] [Full Text] [Related]

  • 12. Outcomes of ambulatory rehabilitation programmes following botulinum toxin for spasticity in adults with stroke.
    Demetrios M, Gorelik A, Louie J, Brand C, Baguley IJ, Khan F.
    J Rehabil Med; 2014 Sep 24; 46(8):730-7. PubMed ID: 25073939
    [Abstract] [Full Text] [Related]

  • 13. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
    Rosales RL, Kong KH, Goh KJ, Kumthornthip W, Mok VC, Delgado-De Los Santos MM, Chua KS, Abdullah SJ, Zakine B, Maisonobe P, Magis A, Wong KS.
    Neurorehabil Neural Repair; 2012 Sep 24; 26(7):812-21. PubMed ID: 22371239
    [Abstract] [Full Text] [Related]

  • 14. Combination therapy with repetitive facilitative exercise program and botulinum toxin type A to improve motor function for the upper-limb spastic paresis in chronic stroke: A randomized controlled trial.
    Hokazono A, Etoh S, Jonoshita Y, Kawahira K, Shimodozono M.
    J Hand Ther; 2022 Sep 24; 35(4):507-515. PubMed ID: 33820711
    [Abstract] [Full Text] [Related]

  • 15. Extracorporeal Shock Waves Versus Botulinum Toxin Type A in the Treatment of Poststroke Upper Limb Spasticity: A Randomized Noninferiority Trial.
    Wu YT, Yu HK, Chen LR, Chang CN, Chen YM, Hu GC.
    Arch Phys Med Rehabil; 2018 Nov 24; 99(11):2143-2150. PubMed ID: 30392753
    [Abstract] [Full Text] [Related]

  • 16. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity.
    Demetrios M, Khan F, Turner-Stokes L, Brand C, McSweeney S.
    Cochrane Database Syst Rev; 2013 Jun 05; (6):CD009689. PubMed ID: 23740539
    [Abstract] [Full Text] [Related]

  • 17. The Effectiveness of Botulinum Toxin Type A (BoNT-A) Treatment in Brazilian Patients with Chronic Post-Stroke Spasticity: Results from the Observational, Multicenter, Prospective BCause Study.
    Khan P, Riberto M, Frances JA, Chueire R, Amorim ACFG, Xerez D, Chung TM, Mercuri LHC, Longo AL, Lianza S, Maisonobe P, Ruiz-Schutz VC.
    Toxins (Basel); 2020 Dec 04; 12(12):. PubMed ID: 33291807
    [Abstract] [Full Text] [Related]

  • 18. Upper Limb Motor Function Affects the Outcome after Treatment with Botulinum Toxin A.
    Fujimura K, Kagaya H, Onaka H, Nagasawa N, Ishihara A, Okochi Y, Yamada M, Tanikawa H, Kanada Y, Saitoh E.
    Eur Neurol; 2019 Dec 04; 81(1-2):30-36. PubMed ID: 31013501
    [Abstract] [Full Text] [Related]

  • 19. Goal Attainment Scaling in Individuals with Upper Limb Spasticity Post Stroke.
    Eftekhar P, Mochizuki G, Dutta T, Richardson D, Brooks D.
    Occup Ther Int; 2016 Dec 04; 23(4):379-389. PubMed ID: 27696580
    [Abstract] [Full Text] [Related]

  • 20. The effect of botulinum toxin-A on neural and non-neural components of wrist hyper-resistance in adults with stroke or cerebral palsy.
    Andringa A, van Wegen E, van de Port I, Guit L, Polomski W, Kwakkel G, Meskers C.
    PM R; 2022 Apr 04; 14(4):486-495. PubMed ID: 33811454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.